Novavax, Inc. — Revenue by Fiscal Year
16 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/248608ab-8b49-431b-8513-a905f1959e4d/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $1.1B | 2025-01-01 – 2025-12-31 | evidence 0001000694-26-000007 |
| FY 2024 | $682.2M | 2024-01-01 – 2024-12-31 | evidence 0001000694-25-000004 |
| FY 2023 | $983.7M | 2023-01-01 – 2023-12-31 | evidence 0001000694-25-000004 |
| FY 2022 | $2.0B | 2022-01-01 – 2022-12-31 | evidence 0001000694-25-000004 |
| FY 2021 | $1.1B | 2021-01-01 – 2021-12-31 | evidence 0001000694-22-000004 |
| FY 2020 | $475.6M | 2020-01-01 – 2020-12-31 | evidence 0001000694-21-000004 |
| FY 2019 | $18.7M | 2019-01-01 – 2019-12-31 | evidence 0001104659-20-031944 |
| FY 2018 | $34.3M | 2018-01-01 – 2018-12-31 | evidence 0001144204-19-014640 |
| FY 2017 | $31.2M | 2017-01-01 – 2017-12-31 | evidence 0001144204-18-014686 |
| FY 2016 | $15.4M | 2016-01-01 – 2016-12-31 | evidence 0001144204-17-011334 |
| FY 2015 | $36.2M | 2015-01-01 – 2015-12-31 | evidence 0001144204-16-084770 |
| FY 2014 | $30.7M | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-012379 |
| FY 2013 | $20.9M | 2013-01-01 – 2013-12-31 | evidence 0001144204-14-014965 |
| FY 2012 | $22.1M | 2012-01-01 – 2012-12-31 | evidence 0001144204-13-014545 |
| FY 2011 | $14.7M | 2011-01-01 – 2011-12-31 | evidence 0001144204-13-014545 |
| FY 2010 | $343.0k | 2010-01-01 – 2010-12-31 | evidence 0001144204-13-014545 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).